Nektar Therapeutics (NKTR) News Today $25.01 -0.09 (-0.36%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$24.74 -0.28 (-1.10%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NKTR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Wealth Enhancement Advisory Services LLC Purchases New Shares in Nektar Therapeutics (NASDAQ:NKTR)July 12 at 3:05 AM | marketbeat.comQ2 EPS Forecast for Nektar Therapeutics Lowered by AnalystJuly 12 at 2:45 AM | americanbankingnews.comNektar Therapeutics (NASDAQ:NKTR) Receives $84.17 Consensus PT from AnalystsJuly 11 at 2:54 AM | americanbankingnews.comQ2 EPS Estimate for Nektar Therapeutics Reduced by AnalystJuly 10 at 8:17 AM | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Shares Sold by Peapod Lane Capital LLCJuly 10 at 7:26 AM | marketbeat.com49 Wealth Management LLC Buys New Holdings in Nektar Therapeutics (NASDAQ:NKTR)July 9, 2025 | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Given New $85.00 Price Target at B. RileyJuly 9, 2025 | americanbankingnews.comB. Riley Raises Nektar Therapeutics (NASDAQ:NKTR) Price Target to $85.00July 8, 2025 | marketbeat.comNektar Therapeutics (NASDAQ:NKTR) Receives Consensus Rating of "Buy" from BrokeragesJuly 8, 2025 | marketbeat.comNektar Therapeutics Reports Positive Phase 2b Results for Eczema Treatment RezpegaldesleukinJuly 6, 2025 | msn.comWhy Nektar Therapeutics Stock Dived by 3% TodayJuly 3, 2025 | fool.comWhat is Zacks Research's Estimate for NKTR FY2025 Earnings?July 3, 2025 | marketbeat.comNektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesJuly 2, 2025 | prnewswire.comQ2 EPS Estimate for Nektar Therapeutics Lowered by AnalystJuly 2, 2025 | marketbeat.comNektar Therapeutics Announces Public Offering of SharesJuly 1, 2025 | tipranks.comNektar Therapeutics stock dips after pricing $100M stock offeringJuly 1, 2025 | seekingalpha.comNektar Therapeutics Announces Pricing of $100 Million Public OfferingJuly 1, 2025 | prnewswire.comNektar Therapeutics launches proposed public offeringJune 30, 2025 | msn.comNektar Therapeutics stock falls after announcing public offeringJune 30, 2025 | in.investing.comNektar Therapeutics Announces Proposed Public OfferingJune 30, 2025 | prnewswire.comBiotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big GainsWith major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?June 30, 2025 | marketbeat.comNektar Jumps 157% on Drug Trial Data-Can It Go Even Higher?June 28, 2025 | msn.comNektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?Nektar Therapeutics soared 157% after Rezpeg succeeded in a Phase 2b eczema trial. Analysts forecast huge upside—here’s why there could be more gains ahead.June 28, 2025 | marketbeat.comNektar Therapeutics Regains Nasdaq Compliance by June 2025June 27, 2025 | tipranks.comNektar Therapeutics Scores Big Phase 2b Win With RezpegJune 27, 2025 | seekingalpha.comHC Wainwright Analysts Boost Earnings Estimates for NKTRJune 27, 2025 | marketbeat.comResearch Analysts Set Expectations for NKTR Q1 EarningsJune 26, 2025 | marketbeat.comRhumbline Advisers Purchases 41,948 Shares of Nektar Therapeutics (NASDAQ:NKTR)June 26, 2025 | marketbeat.comWhy Nektar Therapeutics Stock Was Red-Hot TodayJune 25, 2025 | fool.comNektar Therapeutics (NKTR) Jumps as Eczema Trial SucceedsJune 25, 2025 | gurufocus.comNektar Therapeutics surge continues as stock up another 25%June 25, 2025 | seekingalpha.comWhy Is Nektar Therapeutics Stock Trading Higher On Wednesday?June 25, 2025 | benzinga.comNektar Therapeutics stock soars after atopic dermatitis drug hits key targetsJune 25, 2025 | ca.investing.comNektar Therapeutics Stock Doubles After Promising Eczema Drug Trial ResultsJune 24, 2025 | msn.comNektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising FurtherJune 24, 2025 | msn.comBTIG Research Forecasts Strong Price Appreciation for Nektar Therapeutics (NASDAQ:NKTR) StockJune 24, 2025 | marketbeat.comNektar Therapeutics Is Up 150%: What's Happening With NKTR Stock?June 24, 2025 | forbes.comNektar Therapeutics (NKTR) Sees Dramatic Price Target Increase | NKTR Stock NewsJune 24, 2025 | gurufocus.comHC Wainwright Issues Positive Forecast for Nektar Therapeutics (NASDAQ:NKTR) Stock PriceJune 24, 2025 | marketbeat.comNektar Therapeutics Shares Double On Promising Eczema Drug DataJune 24, 2025 | benzinga.comNektar Therapeutics Announces Positive Phase 2b Trial ResultsJune 24, 2025 | tipranks.comNektar Therapeutics' experimental eczema drug meets main goals of mid-stage trialJune 24, 2025 | reuters.comREZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic DermatitisJune 24, 2025 | prnewswire.comWhy Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving PremarketJune 24, 2025 | benzinga.comNektar Therapeutics Stock Rallies Sharply After-Hours With Major Skin Drug Results Just Hours AwayJune 24, 2025 | msn.comStocks to Watch: Nektar Therapeutics, AlsetJune 23, 2025 | marketwatch.comNektar Stock Soars Ahead of Dermatitis Drug Study DataJune 23, 2025 | marketwatch.comNektar Therapeutics stock soars on upcoming atopic dermatitis dataJune 23, 2025 | investing.comNektar to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin, a Regulatory T-cell Proliferator, in Atopic Dermatitis on June 24, 2025June 23, 2025 | prnewswire.comZacks Research Issues Optimistic Forecast for NKTR EarningsJune 23, 2025 | marketbeat.com Get Nektar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter. Email Address NKTR Media Mentions By Week NKTR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NKTR News Sentiment▼0.640.99▲Average Medical News Sentiment NKTR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NKTR Articles This Week▼155▲NKTR Articles Average Week Get Nektar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PCRX News Today OMER News Today ASMB News Today CPIX News Today LLY News Today JNJ News Today ABBV News Today MRK News Today PFE News Today BMY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NKTR) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NKTR Stock Alerts